Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27.6M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
301K
-
Shares change
-
-22.9M
-
Total reported value, excl. options
-
$307K
-
Value change
-
-$9.57M
-
Number of sells
-
-10
-
Price
-
$1.02
Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q3 2024
11 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q3 2024.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 301K shares
of 27.6M outstanding shares and own 1.09% of the company stock.
Largest 10 shareholders include JOHNSON & JOHNSON (192K shares), 8VC GP I, LLC (109K shares), UBS Group AG (0 shares), XTX Topco Ltd (0 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (0 shares), ORBIMED ADVISORS LLC (0 shares), Raymond James Financial Services Advisors, Inc. (0 shares), PNC Financial Services Group, Inc. (0 shares), BARCLAYS PLC (0 shares), and RENAISSANCE TECHNOLOGIES LLC (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.